| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.08. | Diaceutics und PCC starten Studie zur Konkordanz von NGS-Krebstests | 1 | Investing.com Deutsch | ||
| 20.08. | Diaceutics and PCC launch study on cancer testing accuracy | 1 | Investing.com | ||
| 20.08. | Diaceutics PLC - Diaceutics and PCC launch NGS Concordance Study | - | RNS | ||
| DIACEUTICS Aktie jetzt für 0€ handeln | |||||
| 04.08. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan & TVRs | - | RNS | ||
| 29.07. | Diaceutics PLC - 75% ARR Growth Drives Revenue & Profit Visibility | - | RNS | ||
| 03.07. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan and TVRs | - | RNS | ||
| 25.06. | Diaceutics PLC - Result of AGM | 1 | RNS | ||
| 01.06. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan & TVRs | - | RNS | ||
| 29.05. | Diaceutics PLC - Notice of AGM & Posting of Annual Report | - | RNS | ||
| 26.05. | Diaceutics says order book and pipeline provides confidence for 2026 | 1 | Alliance News | ||
| 26.05. | Diaceutics PLC - Final Results | - | RNS | ||
| 13.05. | Diaceutics PLC - Notice of Results | - | RNS | ||
| 12.05. | Diaceutics PLC - Holding(s) in Company | - | RNS | ||
| 05.05. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan and TVRs | - | RNS | ||
| 16.04. | Diaceutics extends Belfast headquarters lease to 2036 | 1 | Investing.com | ||
| 16.04. | Diaceutics PLC - Related Party Transaction - Lease Extension | 1 | RNS | ||
| 01.04. | Diaceutics PLC - PDMR Shareholding/SIP & Total Voting Rights | - | RNS | ||
| 03.03. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan and TVRs | - | RNS |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 2,300 | 0,00 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| SENSEONICS | 8,000 | 0,00 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration... ► Artikel lesen | |
| VYOME | 2,280 | 0,00 % | Vyome Holdings, Inc - 8-K, Current Report | ||
| INTELLIGENT BIO SOLUTIONS | 2,260 | 0,00 % | Intelligent Bio Solutions GAAP EPS of -$8.44, revenue of $4.22M | ||
| PAVMED | 4,355 | +6,87 % | PAVmed Inc.: PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results | Veris Health accelerated its commercial engagement with OSU-The James
Veris Health implantable physiological monitor achieved development milestones towards upcoming... ► Artikel lesen | |
| FRESENIUS | 46,345 | +1,09 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen Euro | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,260 | -1,11 % | Siemens-Healthineers-Chef: 'Mir gefällt dieses Rumgenörgel nicht' | BERLIN (dpa-AFX) - Der Vorstandvorsitzende des Dax -Konzerns Siemens Healthineers, Bernhard Montag, hat die Anspruchshaltung vieler Wirtschaftslenker in Deutschland gegenüber der Politik kritisiert.... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 61,36 | +0,02 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,360 | 0,00 % | Fresenius macht bei FMC Kasse - was jetzt zählt | ||
| ALIGNMENT HEALTHCARE | 13,920 | +0,14 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| HEARTFLOW | 48,920 | -0,04 % | Biotech Stocks At 52-Week Highs - Vogenx, Pharvaris, Solventum, Inhibikase Therapeutics, HeartFlow | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on August 24, 2026, driven by positive results from clinical trials or an upcoming conference participation. Vogenx... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,150 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 31,280 | -2,00 % | 2,2 Milliarden Menschen mit Sehbeeinträchtigungen: Warum Augengesundheit für Carl Zeiss Meditec, Alcon & Co. zum Technologiemarkt wird - und wo Rise Nano Optics ins Spiel kommt | ||
| AVEANNA HEALTHCARE | 13,605 | -0,11 % | Aveanna Healthcare (AVAH) Just Ended A Four-Year Rate Fight |